Evidence map›Paper›PMID 37330476›Full record

ArticleBMC health services research2023

How can patient registries facilitate guideline-based healthcare? A retrospective analysis of the CEDATA-GPGE registry for pediatric inflammatory bowel disease.

M Leiz, M Knorr, K Moon, L Tischler, K Sohrabi, S Cantez, J Däbritz, J de Laffolie, N van den Berg, CEDATA GPGE Study Group

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06606756 (CEDATA GPGE Patient Registry for Children and Adolescents With IBD), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06606756 recruitingnot on this map

CEDATA GPGE Patient Registry for Children and Adolescents With IBD

Typeobservational_patient_registrySponsorUniversity of GiessenRan2004 to 2034Enrolled6,300ConditionsInflammatory Bowel Disease (IBD)ArmsPatient Registry without intervention, Digital Registry and Feedback on clinical data
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

M Leiz *Institute for Community Medicine, University Medicine, Greifswald, Germany. maren.leiz@jade-hs.de.
M Knorr *Institute for Community Medicine, University Medicine, Greifswald, Germany.
K MoonInstitute for Community Medicine, University Medicine, Greifswald, Germany.
L TischlerInstitute for Community Medicine, University Medicine, Greifswald, Germany.
K SohrabiTechnical University of Applied Sciences, Giessen, Germany.
S CantezGeneral Pediatrics & Neonatology, Justus-Liebig-University, Giessen, Germany.
J DäbritzDepartment of Pediatrics, Greifswald University Medical Center, Greifswald, Germany.
J de Laffolie *General Pediatrics & Neonatology, Justus-Liebig-University, Giessen, Germany.
N van den Berg *Institute for Community Medicine, University Medicine, Greifswald, Germany.
CEDATA GPGE Study Group
Universitätsmedizin Greifswald · DEJustus-Liebig-Universität Gießen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly diagnosis is mandatory for the medical care of children and adolescents with pediatric-onset inflammatory bowel disease (PIBD). International guidelines ('Porto criteria') of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommend medical diagnostic procedures in PIBD. Since 2004, German and Austrian pediatric gastroenterologists document diagnostic and treatment data in the patient registry CEDATA-GPGE on a voluntary basis. The aim of this retrospective study was to analyze whether the registry CEDATA-GPGE reflects the Porto criteria and to what extent diagnostic measures of PIBD according to the Porto criteria are documented.

methodsData of CEDATA-GPGE were analyzed for the period January 2014 to December 2018. Variables representing the Porto criteria for initial diagnostic were identified and categorized. The average of the number of measures documented in each category was calculated for the diagnoses CD, UC, and IBD-U. Differences between the diagnoses were tested by Chi-square test. Data on possible differences between data documented in the registry and diagnostic procedures that were actually performed were obtained via a sample survey.

resultsThere were 547 patients included in the analysis. The median age of patients with incident CD (n = 289) was 13.6 years (IQR: 11.2-15.2), of patients with UC (n = 212) 13.1 years (IQR: 10.4-14.8) and of patients with IBD-U (n = 46) 12.2 years (IQR: 8.6-14.7). The variables identified in the registry fully reflect the recommendations by the Porto criteria. Only the disease activity indices PUCAI and PCDAI were not directly provided by participants but calculated from obtained data. The category 'Case history' were documented for the largest part (78.0%), the category 'Imaging of the small bowel' were documented least frequently (39.1%). In patients with CD, the categories 'Imaging of the small bowel' (χ

conclusionThe registry fully reproduces the guideline's recommendations for the initial diagnosis of PIBD. The proportion of documented diagnostic examinations varied within the diagnostic categories and between the diagnoses. Despite technological innovations, time and personnel capacities at participating centers and study center are necessary to ensure reliable data entry and to enable researchers to derive important insights into guideline-based care.

Indexed as

Crohn DiseaseInflammatory Bowel DiseasesAdolescentChildDelivery of Health CareHumansRegistriesRetrospective StudiesPediatric inflammatory bowel disease (PIBD)RegistryTreatment guidelines

Identifiers

PMID37330476
PMCPMC10276369
OpenAlexW4381094122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.